Table 5 Baseline information in users and non-users of the IDCT.
| Â | IDCT users (n = 313) Mean (SD) | IDCT non-users (n = 2182) Mean (SD) | p |
|---|---|---|---|
Mean age (years) | 62.3 (11.5) | 68.5 (11.6) | <0.0001 |
Mean diabetes duration (years) | 6.5 (6.7) | 7.3 (7.1) | 0.0674 |
Female gender (%) | 46 | 52 | 0.0001 |
HbA1c (%) | 7.8 (1.6) | 7.1 (1.2) | <0.0001 |
SBP (mm Hg) | 136 (16) | 136 (16) | 0.8012 |
DBP (mm Hg) | 81.2 (8.6) | 79.3 (8.9) | 0.0002 |
T. Chol (mg/dl) | 197 (39) | 191 (41) | 0.0223 |
LDL-C (mg/dl) | 111 (32) | 108 (34) | 0.1181 |
HDL-C (mg/dl) | 53 (16) | 54 (15) | 0.4763 |
BMI | 30.4 (5.3) | 29.5 (5.3) | 0.0087 |
Duration of insulin therapy | 6.2 (7.3) | 7.9 (7.6) | 0.1820 |
Education level | Â | Â | Â |
Low education level (%) | 40 | 50 | 0.0002 |
High education level (%) | 20 | 17 | 0.0669 |
Proportion of patients with: | Â | Â | Â |
HbA1c < 8% | 62 | 84 | <0.0001 |
HbA1c < 7% | 37 | 57 | <0.0001 |
SBP ≤ 130 (mm Hg) | 48 | 50 | 0.4892 |
LDL-C < 100 (mg/dl) | 36 | 42 | 0.0621 |
Non smoker (%) | 88 | 85 | 0.3332 |
Healthy Diet (%) | 63 | 67 | 0.1201 |
Physical Exercise (%) | 59 | 52 | 0.3597 |
Aspirin/clopidogrel (%) | 35 | 37 | 0.0952 |
ACE/A2A treatment (%) | 31 | 34 | 0.1945 |
Statin (%) | 37 | 40 | 0.3424 |
Metformin if obesity (%) | 71 | 58 | 0.0008 |
Insulin (%) | 16 | 20 | 0.1063 |
Complications (microangiopathic) | 86 | 71 | 0.1351 |